Effects of Metoprolol on Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention (Type 4a MI): An Inverse Probability of Treatment Weighting Analysis

Background: Metoprolol is the most used cardiac selective β-blocker and has been recommended as a mainstay drug in the management of acute myocardial infarction (AMI). However, the evidence supporting this regimen in periprocedural myocardial infarction (PMI) is limited.Methods: This study identifie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Duanbin Li, Ya Li, Maoning Lin, Wenjuan Zhang, Guosheng Fu, Zhaoyang Chen, Chongying Jin, Wenbin Zhang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/ce6038ee9d6144029ee7446367b6e7da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!